Lipocine (LPCN)
(Delayed Data from NSDQ)
$3.02 USD
+0.05 (1.52%)
Updated Aug 13, 2025 03:41 PM ET
After-Market: $3.01 -0.01 (-0.17%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Lipocine Inc. has a market cap of $16.09M, which represents its share price of $2.97 multiplied by its outstanding shares number of 5.42M. As a small-cap company, LPCN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LPCN 3.02 +0.05(1.52%)
Will LPCN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LPCN based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for LPCN
Lipocine GAAP EPS of -$0.41, revenue of $0.62M
Lipocine (LPCN) Sees Significant Revenue Growth in Q2
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2025 | LPCN Stock News
Lipocine reports Q2 EPS (41c) vs. (57c) last year
Lipocine Inc Reports Q2 2025 Earnings: EPS of ($0.41) Misses Estimates, Revenue of $0. ...